novel-business-models-for-accessible-monoclonal-antibodies-for-infectious-diseases-in-low-and-middle-income-countries-recommendations-from-a-multistakeholder-meeting-convened-by-unitaid-iavi-the-m

Novel business models for accessible monoclonal antibodies for infectious diseases in LMICS: Multistakeholder meeting recommendations